Augmenting solute clearance in peritoneal dialysis

Kidney International

Volumn 54, Issue 6, 1998, Pages 2218-2225

  Krediet, Raymond T ^a,b   Douma, Caroline E ^a   Van Olden, Rudolf W ^a   Ho dac pannekeet, Marja M ^a   Struijk, Dirk G ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Clearance; Diffusion in the peritoneum; Drained dialysate volume; GFR; Low molecular weight solutes; Residual renal function; Transport

Indexed keywords

CONFERENCE PAPER; DIALYSATE; GLOMERULUS FILTRATION; HUMAN; KIDNEY CLEARANCE; KIDNEY FUNCTION; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

EID: 0031727180     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00181.x     Document Type: Conference Paper

References (48)

1. CHURCHILL DN, TAYLOR DW, KESHEVIAH PR, CANUSA PERITONEAL DIALYSIS STUDY GROUP: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7:148-207, 1996
2. GOLPER TA, CHURCHILL D, BURKART J, FIRAREK C, GEARY D, GOTCH F, MOORE LW, NOLPH KD, POWE N, SINGH H, TEEKAN B, TZAMALOUKAS A, WARADY B: NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 30(Suppl 2):S67-S136, 1997
3. COLES GA: Have we underestimated the importance of fluid balance for the survival of PD patients? Pent Dial Int 17:321-326, 1997
4. TWARDOWSKI ZJ, NOLPH KD, KHANNA R, PROWANT BF, RYAN LP, MOORE HL, NIELSEN MP: Peritoneal equilibration test. Perit Dial Bull 7:138-147, 1987
5. PANNEKEET MM, IMHOLZ ALT, STRUIJK DG, KOOMEN GCM, LANGEDIJK MJ, SCHOUTEN N, DE WAART DR, HIRALALL JK, KREDIET RT: The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 48:866-875, 1995
6. JAGER KJ, MERKUS MP, DEKKER FW, BOESCHOTEN EW, KREDIET RT: Patient characteristics at baseline are predictors for patient survival: Contribution of dialysis adequacy remains uncertain. (abstract) Pent Dial Int 18:105, 1998
7. SHEMESH O, GOLBETZ H, KRISS JP, MYERS BD: Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 28:830-838, 1985
8. LAVENDER R, HILTON PJ, JONES NF: The measurement of glomerular filtration rate in renal disease. Lancet 2:1216-1218, 1969
9. MILUTINOVIC J, CUTLER RE, HOOVER P, MEIJSEN B, SCRIBNER BH: Measurement of residual glomerular filtration rate in the patient receiving repetitive hemodialysis. Kidney Int 8:185-190, 1975
10. VAN OLDEN RW, KREDIET RT, STRUIJK DG, ARISZ L: Measurement of residual renal function in patients treated with CAPD. J Am Soc Nephrol 7:745-750, 1996
11. VAN OLDEN RW, VAN ACKER BAC, KOOMEN GCM, KREDIET RT, ARISZ L: Contribution of tubular anion and cation secretion to residual renal function in chronic dialysis patients. Clin Nephrol 49:167-172, 1998
12. CANCARINI GC, BRUNORI G, CAMERINI C, BRASS S, MANILI L, MAIORCA R: Renal function recovery and maintenance of residual diuresis in CAPD and hemodialysis. Perit Dial Bull 6:77-79, 1986
13. LYSAGHT MJ, VONESH EF, GOTCH F, IBELS L, KEEN M, LINDHOLM B, NOLPH KD, POLLOCK CA, PROWANT B, FARRELL PC: The influence of dialysis treatment modality on the decline of remaining renal function. ASAIO Trans 37:598-604, 1996
14. ROTTEMBOURG J: Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int 43(Suppl 40):S106-S110, 1993
15. FALLER B, LAMEIRE N: Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant 9:280-286, 1994
16. VAN OLDEN RW: Residual Renal Function in Dialysis Patients: Pathophysiological Aspects and Effects of High-Dose Furosemide. Thesis, Amsterdam, 1998
17. BONOMINI V, FELETTI C, SCOLARI M, STEFONI S: Benefits of early initiation of dialysis. Kidney Int 28(Suppl 17):S57-S59, 1985
18. IMHOLZ ALT, KOOMEN GCM, STRUUK DG, ARISZ L, KREDIET RT: Effect of dialysate osmolarity on the transport of low-molecular weight solutes and proteins during CAPD. Kidney Int 43:1339-1346, 1993
19. KREDIET RT, BOESCHOTEN EW, STRUIJK DG, ARISZ L: Differences in peritoneal transport of water, solutes and proteins between dialysis with two- and with three-litre exchanges. Nephrol Dial Transplant 2:198-204, 1988
20. TWARDOWSKI ZJ, PROWANT BF, NOLPH KD, MARTINEZ AJ, LAMPTON LM: High volume, low frequency continuous ambulatory peritoneal dialysis. Kidney Int 23:64-70, 1983
21. IMHOLZ ALT, KOOMEN GCM, STRUIJK DG, ARISZ L, KREDIET RT: Effect of an increased intraperitoneal pressure on fluid and solute transport during CAPD. Kidney Int 44:1078-1085, 1993
22. WANG T, HEIMBÜRGER O, CHENG HH, WANIEWSKI J, BERGSTRÖM J, LINDHOLM B: Effect of increased dialysate fill volume on peritoneal fluid and solute transport. Kidney Int 52:1068-1076, 1997
23. BOEN ST: Kinetics of peritoneal dialysis. Medicine 40:243-287, 1961
24. VONESH EF, BURKART J, MCMURRAY SD, WILLIAMS P: Peritoneal dialysis kinetic modelling: Validation in a multicenter clinical study. Perit Dial Int 16:471-481, 1996
25. HO-DAC-PANNEKEET MM, SCHOUTEN N, LANGEDIJK MJ, HIRALALL JK, DE WAART DR, STRUIJK DG, KREDIET RT: Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int 50: 979-986, 1996
26. KREDIET RT: Advances in peritoneal dialysis: Towards improved efficacy and safety. Blood Purif 16:1-14, 1998
27. MISTRY CD, GOKAL R, PEERS E, MIDAS STUDY GROUP: A randomized multicenter clinical trial comparing isoosmolar icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 46:496-503, 1994
28. MACTIER RA, KHANNA R, TWARDOWSKI ZJ, MOORE H, NOLPH KD: Influence of phosphatidylcholine on lymphatic absorption during peritoneal dialysis in the rat. Perit Dial Int 8:179-186, 1988
29. STRUIJK DG, VAN DER REIJDEN HJ, KREDIET RT, KOOMEN GCM, ARISZ L: Effect of phosphatidylcholine on peritoneal transport and lymphatic absorption in a CAPD patient with sclerosing peritonitis. Nephron 51:577-578, 1989
30. KRACK G, VIGLINO G, CAVALLI PL, GANDOLFO C, MAGLIANO G, CANTALUPPI A, PELUSO F: Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 12:359-364, 1992
31. BARANOWKA-DASA E, TORNELI J, POPOVICH RP, MONCRIEF J: Use of bethanechol chloride to increase available ultrafiltration in CAPD. Adv Perit Dial 11:69-72, 1995
32. WANG T, CHEN C, HEIMBÜRGER O, WANIEWSKI J, BERGSTRÖM J, LINDHOLM B: Hyaluronan decreases peritoneal fluid absorption in peritoneal dialysis. J Am Soc Nephrol 8:1915-1920, 1997
33. KREDIET RT, ZEMEL D, IMHOLZ ALT, KOOMEN GCM, STRUIJK DG, ARISZ L: Indices of peritoneal permeability and surface area. Perit Dial Int 13(Suppl 2):S31-S34, 1993
34. KREDIET RT, ZEMEL D, IMHOLZ ALT, STRUIJK DG: Impact of surface area and permeability on solute clearances. Perit Dial Int 14(Suppl 3):S70-S77, 1994
35. BROWN EA, KLIGER AS, GOFFINET J, FINHELSTEIN FO: Effect of hypertonic dialysate and vasodilators on peritoneal dialysis clearances in the rat. Kidney Int 13:271-277, 1978
36. MAHER JF, SHEA C, CASSETTA M, HOHNADEL DC: Isoproterenol enhancement of peritoneal permeability. J Dial 1:319-331, 1977
37. FELT J, RICHARD C, MCCAFFREY C, LEVY M: Peritoneal clearance of creatinine and inulin during dialysis in dogs: Effect of splanchnic vasodilators. Kidney Int 16:459-469, 1979
38. NOLPH KD, GHODS AJ, VAN STONE J, BROWN PA: The effects of intraperitoneal vasodilators on peritoneal clearances. ASAIO Trans 22:589-594, 1976
39. ILKER NY, ÖZGÜR S, CETIN S: Effect of papaverine on solute transport in peritoneal dialysis. Int Urol Nephrol 21:119-123, 1989
40. RUBIN J, ADAIR C, BARNES T, BOWER JD: Augmentation of peritoneal clearance by dipyridamole. Kidney Int 22:658-661, 1982
41. RUBIN J, ADAIR C, BOWER JD: A double blind trial of oral dipyridamole in CAPD. Am J Kidney Dis 5:262-266, 1985
42. FAVAZZA A, MONTANERO D, MESSA P, ANTONUCCI F, GROPUZZO M, MIONI G: Peritoneal clearances in hypertensive CAPD patients after oral administration of clonidine, enalapril and nifedipine. Perit Dial Int 12:287-291, 1992
43. RIPLEY EBD, GEHR TWB, KISH CW, SICA DA: Hormonal, blood pressure and peritoneal transport response to short-term ACE inhibition. Perit Dial Int 14:378-383, 1994
44. HIRSZEL P, MAHER JF, CHAMBERLIN M: Augmented peritoneal mass transport with intraperitoneal nitroprusside. J Dial 2:131-142, 1978
45. NOLPH KD, GHODS A, BROWN P, MILLER F, HARRIS P, PYLE K, POPOVICH R: Effects of nitroprusside on peritoneal mass transfer area coefficients and microvascular physiology. ASAIO Trans 23:210-218, 1977
46. NOLPH KD, GHODS AJ, BROWN PA, TWARDOWSKI ZJ: Effects of intraperitoneal nitroprusside on peritoneal clearances in man with variations of dose, frequency of administration and dwell times. Nephrol 24:114-120, 1979
47. DOUMA CE, DE WAART DR, STRUIJK DG, KREDIET RT: The nitric oxide donor nitroprusside intraperitoneally affects peritoneal permeability in CAPD. Kidney Int 51:1885-1892, 1997
48. DOUMA CE, HIRALALL JK, DE WAART DR, STRUIJK DG, KREDIET RT: Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int 53:1014-1021, 1998